Affymetrix is now part of Thermo Fisher Scientific. As the world leader in serving science, we empower our people to advance innovative technologies, develop meaningful solutions, and build rewarding careers.Affymetrix develops and provides products and services to scientists who are studying biology at the cell, protein, and gene level. Scientists are working toward a better understanding of our well-being and how diseases develop and are diagnosed and treated at the individual level (personalized medicine). In animals and plants, understanding how a desired physical trait can be associated with certain genetic markers can lead to better breeding outcomes, e.g., drought-tolerant crops, desirable traits in farm animals.At the core of our GeneChip portfolio is microarray technology where the entire genome of an organism can be placed onto a small piece of material the size of a thumb nail or smaller. Scientists use microarrays to study and understand the genetic make-up of an organism, such as human, wheat, or salmon. One of our microarrays, CytoScan Dx Assay, is the first and only FDA-cleared whole genome blood test to aid physicians in the diagnosis of postnatal developmental delay in children. This type of test has already helped many parents learn about genetic disorders that lead to developmental delay and provides them with knowledge to better manage their child’s healthcare.
Affymetrix is now part of Thermo Fisher Scientific. As the world leader in serving science, we empower our people to advance innovative technologies, develop meaningful solutions, and build rewarding careers.Affymetrix develops and provides products and services to scientists who are studying biology at the cell, protein, and gene level. Scientists are working toward a better understanding of our well-being and how diseases develop and are diagnosed and treated at the individual level (personalized medicine). In animals and plants, understanding how a desired physical trait can be associated with certain genetic markers can lead to better breeding outcomes, e.g., drought-tolerant crops, desirable traits in farm animals.At the core of our GeneChip portfolio is microarray technology where the entire genome of an organism can be placed onto a small piece of material the size of a thumb nail or smaller. Scientists use microarrays to study and understand the genetic make-up of an organism, such as human, wheat, or salmon. One of our microarrays, CytoScan Dx Assay, is the first and only FDA-cleared whole genome blood test to aid physicians in the diagnosis of postnatal developmental delay in children. This type of test has already helped many parents learn about genetic disorders that lead to developmental delay and provides them with knowledge to better manage their child’s healthcare.
Affymetrix is now part of Thermo Fisher Scientific. As the world leader in serving science, we empower our people to advance innovative technologies, develop meaningful solutions, and build rewarding careers.Affymetrix develops and provides products and services to scientists who are studying biology at the cell, protein, and gene level. Scientists are working toward a better understanding of our well-being and how diseases develop and are diagnosed and treated at the individual level (personalized medicine). In animals and plants, understanding how a desired physical trait can be associated with certain genetic markers can lead to better breeding outcomes, e.g., drought-tolerant crops, desirable traits in farm animals.At the core of our GeneChip portfolio is microarray technology where the entire genome of an organism can be placed onto a small piece of material the size of a thumb nail or smaller. Scientists use microarrays to study and understand the genetic make-up of an organism, such as human, wheat, or salmon. One of our microarrays, CytoScan Dx Assay, is the first and only FDA-cleared whole genome blood test to aid physicians in the diagnosis of postnatal developmental delay in children. This type of test has already helped many parents learn about genetic disorders that lead to developmental delay and provides them with knowledge to better manage their child’s healthcare.